EP 0693121 A4 19991103 - MONOCLONAL ANTIBODY 88BV59, SUBCLONES AND METHOD OF MAKING
Title (en)
MONOCLONAL ANTIBODY 88BV59, SUBCLONES AND METHOD OF MAKING
Title (de)
MONOKLONALER ANTIKÖRPER 88BV59, SUBKLONE UND HERSTELLUNGSVERFAHREN
Title (fr)
ANTICORPS MONOCLONAL 88BV59, SUBCLONES ET PROCEDE DE PRODUCTION
Publication
Application
Priority
- US 9501440 W 19950203
- US 19208994 A 19940204
Abstract (en)
[origin: WO9521244A1] This invention relates to monoclonal antibody 88BV59 produced by B-cell lines derived from B-cells of cancer patients actively immunized with autologous tumor antigen. These monoclonal antibodies can be used in both diagnostic procedures and therapy for human cancers.
IPC 1-7
IPC 8 full level
C12N 15/02 (2006.01); C07K 16/30 (2006.01); C12N 5/10 (2006.01); C12P 21/08 (2006.01); C12R 1/91 (2006.01)
CPC (source: EP KR)
C07K 16/18 (2013.01 - KR); C07K 16/30 (2013.01 - EP); C12N 5/10 (2013.01 - KR)
Citation (search report)
- [X] WO 9119797 A1 19911226 - UNIV NEW YORK [US]
- [X] GLASKY M S ET AL: "STABILITY OF SPECIFIC IMMUNOGLOBIN SECRETION BY EBV-TRANSFORMED LYMPHOBLASTOID CELLS AND HUMAN-MURINE HETEROHYBRIDOMAS", HYBRIDOMA, vol. 8, no. 4, 1 August 1989 (1989-08-01), pages 377 - 389, XP000673899
- See references of WO 9521244A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9521244 A1 19950810; AU 1742595 A 19950821; AU 698184 B2 19981029; CA 2158572 A1 19950810; EP 0693121 A1 19960124; EP 0693121 A4 19991103; FI 954700 A0 19951003; FI 954700 A 19951003; JP H08508893 A 19960924; KR 960701987 A 19960328
DOCDB simple family (application)
US 9501440 W 19950203; AU 1742595 A 19950203; CA 2158572 A 19950203; EP 95909472 A 19950203; FI 954700 A 19951003; JP 52077895 A 19950203; KR 19950704282 A 19951002